Physician
Kashif R. Ali,md,pa
Kashif R. Ali,md,pa was paid $8.16M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoKASHIF R. ALI,MD,PA
HOUSTON, TX 77065
HOUSTON, TX 77065
33aNPI1457624082assigned 02/13/2012
33bProvider typePediatrics Physician
28Total paid$8.16M
24GClaims487,702
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#36 of 1,136
Median peer was paid$329K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 991 | $27K | |
| 2019 | 1,359 | $30K | |
| 2020 | 27,552 | $422K | |
| 2021 | 97,566 | $1.97M | |
| 2022 | 111,914 | $2.25M | |
| 2023 | 141,289 | $1.94M | |
| 2024incomplete | 107,031 | $1.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 72,962 | 55,149 | $2.72M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.7% | 8,234 | 8,048 | $708K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.0% | 8,046 | 7,862 | $652K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.6% | 13,656 | 12,588 | $617K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.3% | 9,643 | 8,999 | $512K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.5% | 4,745 | 4,661 | $447K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.2% | 5,490 | 5,018 | $424K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.0% | 29,826 | 13,744 | $325K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.9% | 18,495 | 11,098 | $317K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 14,774 | 13,900 | $214K |
| 99000 | 2.2% | 17,584 | 15,547 | $178K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 1,576 | 1,551 | $138K |
108 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 15,684 | $109K |
| S8301 | Infection control supplies, not otherwise specified | 1.2% | 15,275 | $101K |
| 99381 | 1.1% | 1,248 | $94K | |
| 99383 | <1% | 751 | $70K | |
| 99429 | <1% | 4,024 | $57K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 550 | $49K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,954 | $45K |
| 92551 | <1% | 12,576 | $41K | |
| 99384 | <1% | 400 | $41K | |
| 99382 | <1% | 440 | $40K | |
| 87807 | <1% | 2,870 | $32K | |
| 83655 | <1% | 7,575 | $28K | |
| 90461 | <1% | 11,478 | $27K | |
| 97169 | <1% | 1,260 | $22K | |
| 92587 | <1% | 4,717 | $13K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,894 | $13K |
| 86328 | <1% | 270 | $12K | |
| S8101 | Holding chamber or spacer for use with an inhaler or nebulizer; with mask | <1% | 719 | $12K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,459 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 743 | $11K |
| 69210 | <1% | 287 | $10K | |
| 97802 | <1% | 14,129 | $9K | |
| 96160 | <1% | 13,906 | $7K | |
| 90734 | <1% | 1,789 | $6K | |
| 0071A | <1% | 137 | $5K | |
| 81002 | <1% | 1,554 | $4K | |
| S9441 | Asthma education, non-physician provider, per session | <1% | 222 | $4K |
| 80061 | Lipid panel | <1% | 4,412 | $4K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 636 | $4K |
| 0001A | <1% | 105 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,138 | $3K |
| 96116 | <1% | 47 | $3K | |
| 85018 | <1% | 10,596 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 174 | $2K |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 799 | $2K |
| 90474 | <1% | 293 | $2K | |
| 99001 | <1% | 211 | $1K | |
| 90651 | <1% | 900 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17 | $901.67 |
| 90619 | <1% | 57 | $888.77 | |
| 84030 | <1% | 1,175 | $724.78 | |
| 90670 | <1% | 3,036 | $714.66 | |
| 58301 | <1% | 34 | $700.00 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 957 | $671.98 |
| 0072A | <1% | 17 | $600.00 | |
| 0002A | <1% | 15 | $560.00 | |
| 90658 | <1% | 951 | $545.35 | |
| 90710 | <1% | 1,669 | $541.22 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 1,084 | $525.00 |
| 99402 | <1% | 66 | $448.24 | |
| 90686 | <1% | 737 | $340.01 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $307.98 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,181 | $235.42 |
| 90688 | <1% | 414 | $206.11 | |
| 83525 | <1% | 2,120 | $201.76 | |
| 90716 | <1% | 970 | $165.25 | |
| 90473 | <1% | 161 | $142.64 | |
| 90715 | <1% | 1,223 | $142.60 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 14,900 | $105.00 |
| 90723 | <1% | 979 | $100.83 | |
| 90633 | <1% | 2,716 | $81.32 | |
| 94760 | <1% | 824 | $79.03 | |
| 90696 | <1% | 1,427 | $65.11 | |
| 84466 | <1% | 25 | $60.96 | |
| 90672 | <1% | 109 | $58.24 | |
| A9150 | Non-prescription drugs | <1% | 54 | $55.01 |
| 90673 | <1% | 24 | $35.00 | |
| 83021 | <1% | 13 | $30.34 | |
| 97804 | <1% | 157 | $27.78 | |
| 82728 | <1% | 13 | $22.90 | |
| 90707 | <1% | 957 | $20.04 | |
| 90648 | <1% | 2,084 | $19.74 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 27 | $12.00 |
| 83540 | <1% | 13 | $10.86 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 29 | $7.84 |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | <1% | 507 | $6.71 |
| 90677 | <1% | 1,088 | $3.54 | |
| 90656 | <1% | 157 | $2.26 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 22 | $2.12 |
| 90697 | <1% | 1,552 | $1.69 | |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 23 | $0.63 |
| 90621 | <1% | 513 | $0.38 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $0.14 |
| 3078F | <1% | 14,542 | $0.01 | |
| 3008F | <1% | 24,370 | $0.01 | |
| 3074F | <1% | 13,060 | $0.01 | |
| 91300 | 0% | 142 | $0.00 | |
| 99173 | 0% | 15,453 | $0.00 | |
| 90700 | 0% | 1,126 | $0.00 | |
| M1005 | Tb screening not performed or results not interpreted, reason not given | 0% | 483 | $0.00 |
| 94664 | 0% | 23 | $0.00 | |
| 3077F | 0% | 90 | $0.00 | |
| 99188 | 0% | 73 | $0.00 | |
| 99401 | 0% | 16 | $0.00 | |
| 90698 | 0% | 202 | $0.00 | |
| 3075F | 0% | 1,577 | $0.00 | |
| 90680 | 0% | 2,395 | $0.00 | |
| 2023F | 0% | 2,587 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 14,375 | $0.00 |
| 91307 | 0% | 187 | $0.00 | |
| 90744 | 0% | 133 | $0.00 | |
| 96127 | 0% | 86 | $0.00 | |
| 90647 | 0% | 33 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 100 | $0.00 |
| 90657 | 0% | 208 | $0.00 | |
| 90660 | 0% | 22 | $0.00 | |
| 3080F | 0% | 26 | $0.00 | |
| 3079F | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALI, KASHIF (PRESIDENT)